跳至主要内容
临床试验/DRKS00027327
DRKS00027327已完成不适用

Real-World observational study on the health situation (QoL) and the psychosocial well-being of patients with ulcerative colitis under filgotinib therapy in the long-term course

CED Service GmbH0 个研究点目标入组 202 人开始时间: 2021年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
202

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients with UC between the ages of 18 and 80 years at study inclusion.
  • Patients who are scheduled to receive new initiation therapy with filgotinib as determined by their treating physician.
  • Patients will be prescribed and receive therapy as part of the filgotinib subject information.
  • Optional additional scientific examination for motion profiles: availability of a personal smartphone.

排除标准

  • A planned surgical intervention with inpatient hospital admission
  • A history of malignant disease (except for a Non-Melanoma Skin Cancer - NMSC)
  • Contraindications to therapy with filgotinib analogous to the SmPC

研究者

相似试验